EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+21.48%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.05B
AUM Growth
+$1.05B
(+25%)
Cap. Flow
+$66.2M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
65.79%
Holding
77
New
14
Increased
23
Reduced
19
Closed
12
Top Buys
| 1 |
Natera
NTRA
|
$50.6M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$31.1M |
| 3 |
Sanofi
SNY
|
$29.4M |
| 4 |
Biogen
BIIB
|
$21.4M |
| 5 |
GSK
GSK
|
$19.6M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$96.3M |
| 2 |
Community Health Systems
CYH
|
$29.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$23.3M |
| 4 |
Lantheus
LNTH
|
$14.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$13M |
Sector Composition
| 1 | Healthcare | 97.4% |
| 2 | Communication Services | 0.84% |
| 3 | Financials | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ionis Pharmaceuticals
IONS
$9.73B
| $9.1M | 0.8% |
240,975
+39,142
| +19% | +$1.48M |
|
|
MODN
27
DELISTED
MODEL N, INC.
MODN
| $8.84M | 0.77% |
+217,880
| New | +$8.84M |
|
|
28
Community Health Systems
CYH
$397M
| $8.65M | 0.76% |
2,001,994
-6,839,610
| -77% | -$29.5M |
|
29
Vaxcyte
PCVX
$4.16B
| $8.56M | 0.75% |
+178,453
| New | +$8.56M |
|
30
Liquidia Corp
LQDA
$2.54B
| $8.22M | 0.72% |
1,290,913
-110,530
| -8% | -$704K |
|
31
Apellis Pharmaceuticals
APLS
$3.52B
| $8M | 0.7% |
+154,796
| New | +$8M |
|
32
Vera Therapeutics
VERA
$1.46B
| $7.96M | 0.7% |
411,308
+255,179
| +163% | +$4.94M |
|
|
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $7.51M | 0.66% |
+350,747
| New | +$7.51M |
|
|
TARO
34
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $6.55M | 0.57% |
225,462
+2,079
| +0.9% | +$60.4K |
|
35
Puma Biotechnology
PBYI
$266M
| $6.38M | 0.56% |
1,507,663
+1,958
| +0.1% | +$8.28K |
|
36
Evolus
EOLS
$477M
| $5.36M | 0.47% |
+713,774
| New | +$5.36M |
|
37
Incyte
INCY
$17B
| $5.14M | 0.45% |
+63,996
| New | +$5.14M |
|
38
Guardant Health
GH
$8.26B
| $3.97M | 0.35% |
146,129
-25,352
| -15% | -$690K |
|
|
AMRN
39
Amarin Corp
AMRN
$315M
| $3.97M | 0.35% |
3,284,114
-8,678,630
| -73% | -$10.5M |
|
40
Merus
MRUS
$5.06B
| $2.86M | 0.25% |
184,556
-92,117
| -33% | -$1.43M |
|
|
JBIO
41
Jade Biosciences, Inc. Common Stock
JBIO
$249M
| $2.67M | 0.23% |
+91,252
| New | +$2.67M |
|
42
Pliant Therapeutics
PLRX
$104M
| $2.66M | 0.23% |
137,423
-156,680
| -53% | -$3.03M |
|
43
Cabaletta Bio
CABA
$138M
| $2.62M | 0.23% |
282,874
-277,592
| -50% | -$2.57M |
|
44
Biohaven
BHVN
$1.7B
| $2.58M | 0.23% |
+185,595
| New | +$2.58M |
|
45
IQVIA
IQV
$31B
| $2.23M | 0.2% |
10,889
+2,592
| +31% | +$531K |
|
46
Agilent Technologies
A
$35.3B
| $1.78M | 0.16% |
11,878
-9,643
| -45% | -$1.45M |
|
47
Amneal Pharmaceuticals
AMRX
$3.02B
| $1.65M | 0.14% |
830,960
-3,859,852
| -82% | -$7.68M |
|
48
Xoma
XOMA
$420M
| $1.6M | 0.14% |
86,873
-1,529
| -2% | -$28.1K |
|
49
Revvity
RVTY
$9.78B
| $1.57M | 0.14% |
11,178
+248
| +2% | +$34.8K |
|
50
Bio-Techne
TECH
$8.32B
| $1.38M | 0.12% |
+16,635
| New | +$1.38M |
|